Literature DB >> 21253251

Newer interventions in myocardial infarction: do they make a difference?

D I Peretz.   

Abstract

Preventive aspects of coronary artery disease have made substantial advances in recent years, decreasing the incidence of coronary artery disease in Western countries. In addition to that there has been an initial drop from an in-hospital mortality of 35% to approximately 12% in the early 1960s with the establishment of coronary care units and cardiopulmonary resuscitation with defibrillation. Further to that, in recent years, it has been conclusively shown that there would be a further 20% decrease in mortality and improvement in morbidity in acute myocardial infarcts in patients treated with thrombolytic agents who present themselves within four hours of the onset of their symptoms and who are under 65 years of age. This would decrease the in-hospital mortality to approximately nine percent.

Entities:  

Year:  1988        PMID: 21253251      PMCID: PMC2219168     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  9 in total

1.  CLINICAL MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION.

Authors:  F W HURLBURT; J G GILLIS; D KAVANAGH-GRAY; R A PALMER; B SHALLARD; J A TRAYNOR
Journal:  Can Med Assoc J       Date:  1965-08-28       Impact factor: 8.262

2.  Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.

Authors:  S Yusuf; R Collins; R Peto; C Furberg; M J Stampfer; S Z Goldhaber; C H Hennekens
Journal:  Eur Heart J       Date:  1985-07       Impact factor: 29.983

3.  Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.

Authors:  D G Harrison; D W Ferguson; S M Collins; D J Skorton; E E Ericksen; J M Kioschos; M L Marcus; C W White
Journal:  Circulation       Date:  1984-05       Impact factor: 29.690

4.  Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

Authors:  R S Gibson; W E Boden; P Theroux; H D Strauss; C M Pratt; M Gheorghiade; R J Capone; M H Crawford; R C Schlant; R E Kleiger
Journal:  N Engl J Med       Date:  1986-08-14       Impact factor: 91.245

5.  Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction.

Authors:  J W Kennedy; J L Ritchie; K B Davis; J K Fritz
Journal:  N Engl J Med       Date:  1983-12-15       Impact factor: 91.245

6.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

7.  Intracoronary thrombolysis in evolving myocardial infarction.

Authors:  W Ganz; N Buchbinder; H Marcus; A Mondkar; J Maddahi; Y Charuzi; L O'Connor; W Shell; M C Fishbein; R Kass; A Miyamoto; H J Swan
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

8.  A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction.

Authors:  E J Topol; W W O'Neill; A B Langburd; J A Walton; P D Bourdillon; E R Bates; C L Grines; A M Schork; E Kline; B Pitt
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

9.  Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial.

Authors:  R Erbel; T Pop; K J Henrichs; K von Olshausen; C J Schuster; H J Rupprecht; C Steuernagel; J Meyer
Journal:  J Am Coll Cardiol       Date:  1986-09       Impact factor: 24.094

  9 in total
  1 in total

1.  Myocardial infarction.

Authors:  M C Sosa-Iudicissa
Journal:  Can Fam Physician       Date:  1989-04       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.